Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases
Sign Up to like & getrecommendations! Published in 2018 at "Medical Oncology"
DOI: 10.1007/s12032-018-1137-0
Abstract: To evaluate outcome in patients treated with stereotactic body radiotherapy (SBRT) on bone oligometastases from castration-sensitive prostate cancer after primary treatment. We retrospectively collected data of patients with less than five lesions at time of… read more here.
Keywords: prostate; castration sensitive; body radiotherapy; bone oligometastases ... See more keywords
De Novo, Progressed, and Neglected Metastatic Castration‐Sensitive Prostate Cancer: Is One Therapy Fit for All?
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.07.014
Abstract: &NA; Patients who receive a diagnosis of metastatic castration‐sensitive prostate cancer (CSPC) have different phenotypes of disease. Some of them have de novo CSPC, but others receive a late diagnosis, and still others underwent prostatectomy… read more here.
Keywords: castration sensitive; prostate cancer; metastatic castration; sensitive prostate ... See more keywords
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2020 at "European urology"
DOI: 10.1016/j.eururo.2020.06.033
Abstract: Recently, mutations in speckle-type pox virus and zinc finger protein (SPOP) gene (mutant SPOP [mtSPOP]) have been associated with improved outcomes to abiraterone in the castration-resistant setting. We hypothesized that mtSPOP would be associated with… read more here.
Keywords: men novo; castration sensitive; novo metastatic; metastatic castration ... See more keywords
Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration‐sensitive prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "BJU International"
DOI: 10.1111/bju.14642
Abstract: To identify biomarkers that predict the response to standard androgen deprivation therapy (ADT) of patients newly diagnosed with metastatic castration‐sensitive prostate cancer (CSPC) in order to improve therapeutic decision‐making, and to investigate whether the characterization… read more here.
Keywords: castration sensitive; prostate cancer; metastatic castration; circulating tumour ... See more keywords
Presence of CD133‐positive circulating tumor cells predicts worse progression‐free survival in patients with metastatic castration‐sensitive prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.14801
Abstract: To investigate the clinical significance of the expression of the stemness marker CD133 in circulating tumor cells of newly diagnosed metastatic castration‐sensitive prostate cancer patients. read more here.
Keywords: circulating tumor; prostate cancer; tumor cells; castration sensitive ... See more keywords
Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.14864
Abstract: 1 Mori K, Mostafaei H, Sari Motlagh R et al. Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis. BJU Int. 2021; https://doi.org/10.1111/bju.15507. 2 Kyriakopoulos CE, Chen Y-H, Carducci MA et al. Chemohormonal therapy in… read more here.
Keywords: metastatic castration; prostate cancer; castration sensitive; sensitive prostate ... See more keywords
Abstract 5537: Prognostic impact of sarcopenia in patients with metastatic castration sensitive prostate cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5537
Abstract: Background/Aim: Recently, sarcopenia has been reported to be a useful prognostic factor in cancer patients, including prostate cancer patients. Gleason score, the presence or absence of visceral metastases, and the number of bone metastases, which… read more here.
Keywords: prostate cancer; castration sensitive; risk; sarcopenia ... See more keywords
Comparative effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer: A parametric survival network meta-analysis of randomized controlled trials.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.5532
Abstract: 5532Background: Treatment decision-making for metastatic castration-sensitive prostate cancer (mCSPC) is complicated by the unclear comparative effectiveness and widely varying costs of competing s... read more here.
Keywords: castration sensitive; prostate cancer; metastatic castration; comparative effectiveness ... See more keywords
Genomic analysis of castration sensitive and resistant prostate cancer patients by multiple-gene targeted sequencing.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e17525
Abstract: e17525Background: Previous studies showed the significant diversity of the genomic landscapes between castration sensitive prostate cancer (CSPC) and castration resistant prostate cancer (CRPC). AR... read more here.
Keywords: castration sensitive; castration; resistant prostate; prostate cancer ... See more keywords
Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
Sign Up to like & getrecommendations! Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12355
Abstract: Background/Aim: Although upfront combination therapies with androgen deprivation are recommended for patients with castration-sensitive prostate cancer (CSPC), combination therapies may be excessive for some patients. The aim of this study was to identify patients with… read more here.
Keywords: prostate; castration sensitive; cancer; therapy ... See more keywords
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202211_30384
Abstract: In recent years, the advanced knowledge of clinical, biological and molecular features of prostate cancer have led to the introduction of new drugs and have allowed the relocation of old drugs in different settings. In… read more here.
Keywords: castration sensitive; prostate cancer; castration; management systemic ... See more keywords